Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Feb-24 8:37 PM View:  | Disc Medicine, Inc. (IRON) | 07-Feb-24 | Grant | 36,666 | -- | -- | 100% 0 to 36.67K | |
| 07-Aug-23 5:28 PM View: | Biodesix Inc (BDSX) | 03-Aug-23 | Grant | 61,728 | $1.62 | $99,999.40 | 308% 20.04K to 81.77K | |
| 18-May-23 8:32 PM View: | Replimune Group, Inc. (REPL) | 16-May-23 | Sale | 11,351 | $18.05 | $204,886.00 | (8%) 140.1K to 128.75K | |
| 04-Apr-23 8:01 PM View: | Replimune Group, Inc. (REPL) | 01-Apr-23 | Grant | 45,000 | -- | -- | 47% 95.1K to 140.1K | |
| 18-May-22 7:03 PM View: | Replimune Group, Inc. (REPL) | 16-May-22 | Sale | 3,436 | $14.59 | $50,131.20 | (3%) 98.53K to 95.1K | |
| 05-Apr-22 4:17 PM View: | Replimune Group, Inc. (REPL) | 01-Apr-22 | Grant | 52,500 | -- | -- | 114% 46.03K to 98.53K | |
| 04-Apr-22 4:16 PM View: | Biodesix Inc (BDSX) | 31-Mar-22 | Option Exercise | 20,044 | -- | -- | 100% 0 to 20.04K | |
| 05-Apr-21 8:19 PM View: | Replimune Group, Inc. (REPL) | 01-Apr-21 | Grant | 46,035 | -- | -- | 100% 0 to 46.03K | |
| 15-Jan-21 9:01 PM View: | Replimune Group, Inc. (REPL) | 14-Jan-21 | Option Exercise | 14,900 | $14.08 | $209,792.00 | 100% 0 to 14.9K | |
| 15-Jan-21 9:01 PM View: | Replimune Group, Inc. (REPL) | 14-Jan-21 | Market Option Sale (Planned) | 14,900 | $44.53 | $663,465.00 | (100%) 14.9K to 0 | |
| 15-Jan-21 9:01 PM View: | Replimune Group, Inc. (REPL) | 13-Jan-21 | Option Exercise | 100 | $14.08 | $1,408.00 | 100% 0 to 100 | |
| 15-Jan-21 9:01 PM View: | Replimune Group, Inc. (REPL) | 13-Jan-21 | Market Option Sale (Planned) | 100 | $44.19 | $4,419.00 | (100%) 100 to 0 | |
| 16-Dec-20 9:00 PM View: | Replimune Group, Inc. (REPL) | 14-Dec-20 | Option Exercise | 25,000 | $14.08 | $352,000.00 | 100% 0 to 25.0K | (8%) |
| 16-Dec-20 9:00 PM View: | Replimune Group, Inc. (REPL) | 14-Dec-20 | Market Option Sale (Planned) | 25,000 | $43.45 | $1,086,200.00 | (100%) 25.0K to 0 | 4% |